Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
Objective To compare the efficacy and prognosis of imatinib and sirolimus as second-line treatment for steroid-refractory chronic graft-versus-host disease (SR-cGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Methods Clinical data of 33 patients diagnosed as SR-cGVHD afte...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | ZH |
| Publicado: |
Editorial Office of Journal of Third Military Medical University
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/413c7351afd84e67a2f6d92b036de682 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!